Similarly, increased levels of nuclear β-catenin, Akirin-2, and NFκB-p65 proteins were found in imatinib-resistant CML cells [58]. The gene discussed is NFKB1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.